SEQIRUS VACCINES LIMITED
03970089Manufacture of basic pharmaceutical products
SEQIRUS VACCINES LIMITED
Manufacture of basic pharmaceutical products
Previous Company Names
Contact & Details
Contact
Registered Address
Gaskill Road Liverpool Merseyside L24 9GR
Full company profile for SEQIRUS VACCINES LIMITED (03970089), an active life sciences and medical technology company based in Merseyside, United Kingdom. Incorporated 11 Apr 2000. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2013–2025)
Cash in Bank
£4.30M
Net Assets
£143.90M
Total Liabilities
£110.20M
Turnover
£175.20M
Employees
671
Debt Ratio
43%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 30 Jun Year End | 2024 30 Jun Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 56 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Seqirus Limited
Unknown
- Ownership Of Shares 75 To 100 Percent
- Voting Rights 75 To 100 Percent
- Voting Rights 75 To 100 Percent As Firm
- Right To Appoint And Remove Directors
Seqirus Vaccines Holdings Limited
Ceased 13 Mar 2026
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
8 Renaissance Way, Liverpool (L24 9PS) LIVERPOOL | Leasehold | - | 20 Mar 2020 |
Novartis Vaccines & Diagnostics, Gaskill Road, Liverpool (L24 9GR) LIVERPOOL | Freehold | - | 9 Dec 2014 |
Unit 4, Boulevard Industry Park, Speke, Liverpool LIVERPOOL | Leasehold | - | 10 Jul 2009 |
Unit 5a, Boulevard Industry Park, Speke, Liverpool LIVERPOOL | Leasehold | - | 19 Apr 2007 |
land and buildings on the North side of Speke Boulevard, Liverpool LIVERPOOL | Leasehold | - | 5 Sept 2001 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 29 Mar 2026 | Accounts | Annual accounts made up to 30 Jun 2025 | |
| 20 Mar 2026 | Persons With Significant Control | Cessation of Seqirus Vaccines Holdings Limited as a person with significant control on 13 Mar 2026 | |
| 20 Mar 2026 | Confirmation Statement | Confirmation statement made on 26 Feb 2026 with no updates | |
| 20 Mar 2026 | Persons With Significant Control | Seqirus Limited notified as a person with significant control | |
| 16 Mar 2026 | Officers | Change to director Mr Christopher James Thorpe on 19 Aug 2024 |
Annual accounts made up to 30 Jun 2025
Cessation of Seqirus Vaccines Holdings Limited as a person with significant control on 13 Mar 2026
Confirmation statement made on 26 Feb 2026 with no updates
Seqirus Limited notified as a person with significant control
Change to director Mr Christopher James Thorpe on 19 Aug 2024
Recent Activity
Latest Activity
Annual accounts made up to 30 Jun 2025
3 months ago on 29 Mar 2026
Cessation of Seqirus Vaccines Holdings Limited as a person with significant control on 13 Mar 2026
3 months ago on 20 Mar 2026
Confirmation statement made on 26 Feb 2026 with no updates
3 months ago on 20 Mar 2026
Seqirus Limited notified as a person with significant control
3 months ago on 20 Mar 2026
Change to director Mr Christopher James Thorpe on 19 Aug 2024
3 months ago on 16 Mar 2026